folic acid has been researched along with Local Neoplasm Recurrence in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.08) | 18.7374 |
1990's | 2 (4.17) | 18.2507 |
2000's | 22 (45.83) | 29.6817 |
2010's | 20 (41.67) | 24.3611 |
2020's | 3 (6.25) | 2.80 |
Authors | Studies |
---|---|
Long, T; Sun, Y; Yang, Z; Yuan, D; Yue, S; Zhang, N; Zheng, J | 1 |
Baierl, A; Böhm, J; Bours, MJL; Brenner, H; Breukink, SO; Brezina, S; Chang-Claude, J; de Wilt, JHW; Geijsen, AJMR; Gigic, B; Grady, WM; Grünberger, T; Gsur, A; Gumpenberger, T; Habermann, N; Herpel, E; Hoffmeister, M; Holowatyj, AN; Kampman, E; Keulen, ETP; Kiblawi, R; Kok, DE; Koole, JL; Kosma, K; Kouwenhoven, EA; Kvalheim, G; Li, CI; Lin, T; Ose, J; Schirmacher, P; Schneider, M; Schrotz-King, P; Singer, MC; Ueland, PM; Ulrich, AB; Ulrich, CM; Ulvik, A; van Duijnhoven, FJB; van Halteren, HK; van Roekel, EH; Vickers, K; Vogelaar, FJ; Warby, CA; Weijenberg, MP; Wesselink, E | 1 |
Chen, YM; Lao, XQ; Liu, X; Liu, ZZ; Sun, LP; Yan, LB; Zhang, CX; Zhao, WJ | 1 |
Azaïs, H; Collinet, P; Colombeau, L; Delhem, N; Frochot, C; Grabarz, A; Khodja Bach, S; Mordon, S | 1 |
Chen, Z; He, Y; Huang, S; Song, J; Tu, X; Wang, L; Zhang, Z | 1 |
Dinney, CP; Grossman, HB; Lerner, SP; Tu, H; Wu, X; Ye, Y | 1 |
Bora, C; Candiloro, KM; Coleman, TP; Connolly, DC; Davis, B; Galati, CA; Ganta, S; Litwin, S; Maglaty, MA; Morse, AB; Nack, AH; O'Brien, SW; Patel, NR; Piroyan, A; Solon, AL | 1 |
Ariyoshi, N; Hiraoka, E; Koyamada, R | 1 |
Ajaj, AR; Al-Hiary, R; Al-Yacoub, S; Kadi, T; Majdalawi, K; Mukred, R; Tantawi, D; Yousef, AM; Yousef, M; Zawiah, M | 1 |
Chen, X; Gotoh, N; Horike, SI; Igarashi, K; Kato, K; Kita, K; Kohno, S; Meguro-Horike, M; Mukaida, N; Murayama, T; Nakata, A; Nishi, K; Nishimura, T; Saitoh, K; Sasaki, S; Soga, T; Takahashi, C; Tojo, A; Yano, S | 1 |
Chen, HM; Chen, XY; Chen, YX; Fang, DC; Fang, JY; Gao, QY; Ge, ZZ; Sheng, JQ; Tang, JT; Wang, YC; Wang, ZH; Yu, CG; Zheng, P | 1 |
Carroll, PR; Chan, JM; Davies, BJ; O'Keefe, DS; Richman, EL; Sadetsky, N; Tomaszewski, JJ | 1 |
Apollo, A; Cox, L; Fury, MG; Haque, S; Ho, AL; Lipson, BL; Lyo, JK; Pfister, DG; Sales, R; Seetharamu, N; Sherman, EJ; Sima, CS; Xiao, H | 1 |
Aggarwal, C; Albelda, S; Barbosa, EM; DeJesus, E; Deshpande, C; Jiang, J; Judy, R; Low, PS; Nie, S; Okusanya, OT; Simone, CB; Singhal, S | 1 |
Matsumoto, K; Onda, T; Yaegashi, N | 1 |
Berezowska, S; Dorn, P; Froment, L; Hall, SR; Kocher, G; Liang, SQ; Marti, TM; Peng, RW; Schmid, RA | 1 |
Carlsson, G; Gustavsson, B; Odin, E; Sondén, A; Wettergren, Y | 1 |
Ahnen, DJ; Baron, JA; Barry, EL; Bradshaw, PT; Bresalier, RS; Fedirko, V; Figueiredo, JC; Milne, GL; Sandler, RS | 1 |
Pot, GK; van Dijk, M | 1 |
Chen, HM; Ding, H; Fang, JY; Gao, QY | 1 |
Bacich, DJ; Cummings, JL; O'Keefe, DS; Sobek, KM | 1 |
Axelrod, BN; Jaszewski, R; Kucuk, O; Levi, E; Majumdar, AP; Misra, S; Naumoff, JA; Patel, BB; Tobi, M; Ullah, N | 1 |
Ahnen, DJ; Ali, I; Baron, JA; Barry, EL; Figueiredo, JC; Grau, MV; Haile, RW; Levine, AJ; Midttun, O; Munroe, D; Sandler, RS; Tsang, S; Ueland, PM | 1 |
Kim, YI | 1 |
Ahnen, D; Ali, IU; Baron, JA; Barry, EL; Cole, BF; Haile, RW; Levine, AJ; Munroe, DJ; Saibil, F; Tsang, S; Ueland, P; Wallace, K | 1 |
Bromund, JL; Chen, R; Neubauer, M; Obasaju, C; Raju, RN; Reynolds, CH; Richards, DA; Ruxer, RL; Savin, M; Smith, DA; Socinski, MA; Zhan, F | 1 |
Ahnen, DJ; Ali, IU; Baron, JA; Barry, EL; Bresalier, RS; Burke, C; Grau, MV; Gui, J; McKeown-Eyssen, GE; Munroe, DJ; Saibil, F; Sandler, RS; Sansbury, LB; Tsang, S | 1 |
Fuchs, CS; Giovannucci, E; Hunter, DJ; Platz, EA; Rosner, BA; Selhub, J; Willett, WC; Wu, K | 1 |
Baron, JA; Chao, WH; Hazra, A; Hunter, DJ; Selhub, J; Ueland, PM | 1 |
Baron, JA; Grau, MV; Levine, AJ; Mott, LA; Ueland, PM | 1 |
Büchler, MW; Dunn, JA; Friess, H; Ghaneh, P; Hickey, H; Neoptolemos, JP; Raraty, MG; Stocken, DD | 1 |
Burt, RW; Dehdashti, F; Ellis, PR; Gershenson, DM; Green, MA; Mathias, CJ; Mutch, DG; Podoloff, DA; Siegel, BA; Sutton, GP; Wendt, R | 1 |
Omura, K | 1 |
Alberts, DS; Henning, SM; Martínez, ME | 1 |
Medinger, M; Mross, K; Steinbild, S | 1 |
Alberts, DS; Giovannucci, E; Henning, SM; Jacobs, ET; Jiang, R; Martínez, ME; Smith-Warner, SA; Thompson, P | 1 |
Armitage, N; Chau, I; Grainge, M; Houlston, RS; Hubner, RA; Liu, JF; Logan, RF; Muir, KR; Sellick, GS | 1 |
Alberts, DS; Giovannucci, E; Jacobs, ET; Jiang, R; Klimecki, W; Martínez, ME; Thompson, P | 1 |
Braun, M; Fischer, HP; Grünn, U; Hernando, JJ; Kuhn, W; Leutner, C; Park, TW; Pölcher, M; Pötzsch, B; Zivanovic, O | 1 |
Armitage, NC; Grainge, MJ; Logan, RF; Muir, KR; Shepherd, VC | 1 |
Lance, P | 1 |
Berthelot, CN; Duvic, M; Jones, D; Leitenberger, JJ; McLaughlin, P; Polder, KD; Pro, B | 1 |
Albert, PS; Cross, AJ; Kalidindi, A; Laiyemo, A; Lanza, E; Lehman, T; Modali, R; Murphy, G; Sansbury, LB; Schatzkin, A; Stolzenberg-Solomon, R; Wang, Z | 1 |
Lundberg, GD | 1 |
Grainge, MJ; Houlston, RS; Hubner, RA; Liu, JF; Logan, RF; Muir, KR | 1 |
Hoffmann, R | 1 |
Karamanolis, DG; Paspatis, GA | 1 |
Bovo, G; Bratina, G; Brenna, A; Brivio, F; Brivio, O; Fumagalli, L; Lavorato, F; Perego, P; Uggeri, F | 1 |
7 review(s) available for folic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review.
Topics: Alcohol Drinking; Beverages; Diet; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Folic Acid; Humans; Neoplasm Recurrence, Local; Nutritional Status; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate; Vitamin B Complex | 2020 |
Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Carcinoma, Ovarian Epithelial; Deoxycytidine; Doxorubicin; Everolimus; Female; Folic Acid; Gemcitabine; Humans; Indazoles; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Nivolumab; Ovarian Neoplasms; Paclitaxel; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Glycols; Pyrimidines; Quinazolines; Recombinant Fusion Proteins; Sirolimus; Sulfonamides; Topotecan; TOR Serine-Threonine Kinases; Vinca Alkaloids | 2015 |
The effects of nutritional interventions on recurrence in survivors of colorectal adenomas and cancer: a systematic review of randomised controlled trials.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Antioxidants; Cancer Survivors; Colorectal Neoplasms; Dietary Supplements; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nutrition Therapy; Randomized Controlled Trials as Topic; Time; Treatment Outcome | 2016 |
Folic acid supplementation and cancer risk: point.
Topics: Animals; Biomarkers, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Folic Acid; Humans; Neoplasm Recurrence, Local; Neoplasms; Primary Prevention | 2008 |
[Adjuvant and additive therapy for cancer of the pancreas].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Controlled Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Folic Acid; Gemcitabine; Hematinics; Humans; Leucovorin; Male; Mitoxantrone; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Quality of Life; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Surveys and Questionnaires; Time Factors | 2003 |
[Specialized nutrition support for the patients with advanced or recurrent carcinoma of the gastrointestinal tract].
Topics: Enteral Nutrition; Folic Acid; Folic Acid Deficiency; Gastrointestinal Neoplasms; Humans; Neoplasm Recurrence, Local; Nutrition Assessment; Nutrition Disorders; Nutritional Support; Vitamin B 12; Vitamin B 12 Deficiency | 2004 |
[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cetuximab; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colon; Colonic Neoplasms; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Folic Acid; Humans; Leucovorin; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Palliative Care; Postoperative Care; Randomized Controlled Trials as Topic; Time Factors | 2004 |
13 trial(s) available for folic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Topics: Adenoma; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Risk Factors; Vitamin B Complex | 2013 |
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Topics: Adult; Aged; Aminopterin; Carcinoma, Squamous Cell; Disease Progression; Female; Folic Acid; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Vitamin B 12; Vitamin B Complex; Young Adult | 2014 |
Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
Topics: Adenoma; Administration, Oral; Aged; Aspirin; Chromatography, Gas; Chromatography, Liquid; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Female; Folic Acid; Humans; Male; Mass Spectrometry; Middle Aged; Neoplasm Recurrence, Local; Poisson Distribution; Prostaglandins | 2015 |
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Topics: Adenoma; Aged; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Treatment Outcome | 2008 |
Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Topics: Adenoma; Alcohol Drinking; Aspirin; Chemoprevention; Colorectal Neoplasms; Double-Blind Method; Female; Folic Acid; Genotype; Humans; Incidence; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Poisson Distribution; Polymorphism, Genetic; Riboflavin; Risk; Surveys and Questionnaires; Vitamin B 12; Vitamin B 6 | 2008 |
MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
Topics: Adenoma; Alleles; Aspirin; Chi-Square Distribution; Colorectal Neoplasms; Double-Blind Method; Female; Folic Acid; Genotype; Humans; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Placebos; Polymorphism, Genetic | 2008 |
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cohort Studies; Dietary Supplements; Female; Folic Acid; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pemetrexed; Prognosis; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate; Thymidylate Synthase; Vitamin B Complex | 2008 |
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Topics: Adenoma; Aged; Aspirin; Cohort Studies; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Folic Acid; Gene Frequency; Genetic Variation; Genotype; Haplotypes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Risk Assessment | 2009 |
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
Topics: Adenoma; Aged; Colorectal Neoplasms; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies | 2009 |
Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aspirin; Colorectal Neoplasms; Double-Blind Method; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Surveys and Questionnaires; Young Adult | 2010 |
Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence.
Topics: Adenoma; Aged; Colorectal Neoplasms; Diet; Dietary Fiber; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Neoplasm Recurrence, Local; Risk Factors; Ursodeoxycholic Acid; Vitamin B Complex | 2006 |
Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Topics: Adenoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotherapy, Adjuvant; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Female; Folic Acid; Hematinics; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 2008 |
Folate supplementation and adenomatous colonic polyps.
Topics: Adenomatous Polyposis Coli; Colonoscopy; Double-Blind Method; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies | 1994 |
28 other study(ies) available for folic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Folic Acid; Immunogenic Cell Death; Mice; Nanoparticles; Neoplasm Recurrence, Local; Polyethylene Glycols; Tumor Microenvironment | 2022 |
Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.
Topics: Biomarkers; Carbon; Colorectal Neoplasms; Folic Acid; Humans; Neoplasm Recurrence, Local; Prospective Studies; Pyridoxal Phosphate; Vitamin B 6 | 2022 |
[Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Mice; Necrosis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred F344 | 2017 |
Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
Topics: Colorectal Neoplasms; Cystathionine beta-Synthase; DNA; DNA Methylation; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Promoter Regions, Genetic | 2017 |
Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study.
Topics: Aged; Body Mass Index; Diet; Dietary Supplements; Disease Progression; Evidence-Based Medicine; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nutrition Assessment; Proportional Hazards Models; Prospective Studies; Risk Factors; Socioeconomic Factors; Surveys and Questionnaires; Urinary Bladder Neoplasms | 2018 |
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Carriers; Emulsions; Endocytosis; Female; Folate Receptor 1; Folic Acid; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Imaging; Nanoparticles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Theranostic Nanomedicine | 2018 |
Can folate replacement induce lymphoma progression?
Topics: Adult; Disease Progression; Fatal Outcome; Folic Acid; Folic Acid Deficiency; Humans; Lymphoma, T-Cell, Peripheral; Male; Multiple Organ Failure; Neoplasm Recurrence, Local | 2018 |
Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy.
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Folic Acid; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Pharmacogenomic Testing; Polymorphism, Genetic; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2018 |
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
Topics: Aminohydrolases; Aminoimidazole Carboxamide; beta Catenin; Carcinogenesis; Cell Line; Cell Line, Tumor; Drug Resistance, Neoplasm; Folic Acid; Gefitinib; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Lung Neoplasms; Metabolic Networks and Pathways; Methylenetetrahydrofolate Dehydrogenase (NADP); Mitochondria; Multifunctional Enzymes; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Purines; Ribonucleotides | 2019 |
Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.
Topics: Adenocarcinoma; Aged; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Neoplasms | 2014 |
Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Contrast Media; Fluorescein; Folate Receptor 1; Folic Acid; Humans; Lung Neoplasms; Mediastinum; Middle Aged; Molecular Imaging; Monitoring, Intraoperative; Neoplasm Recurrence, Local | 2014 |
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Folic Acid; Folic Acid Antagonists; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Signal Transduction | 2015 |
Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Leucovorin; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Proton-Coupled Folate Transporter; Reduced Folate Carrier Protein; Signal Transduction | 2015 |
People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Female; Folic Acid; Humans; Logistic Models; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Factors; Young Adult | 2016 |
Contrasting roles of the ABCG2 Q141K variant in prostate cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Docetaxel; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasm Proteins; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Taxoids | 2017 |
Uracil misincorporation into DNA and folic acid supplementation.
Topics: Adenoma; Aged; Alcohol Drinking; Aspirin; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; DNA; Female; Folic Acid; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Recurrence, Local; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Uracil | 2010 |
Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.
Topics: Adult; Aged; Carrier Proteins; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Indium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pentetic Acid; Radionuclide Imaging; Receptors, Cell Surface; Sensitivity and Specificity | 2003 |
Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence.
Topics: Adenoma; Adult; Aged; Colorectal Neoplasms; Diet; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; Surveys and Questionnaires | 2004 |
Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
Topics: Adenoma; Adult; Aged; Colorectal Neoplasms; Female; Ferredoxin-NADP Reductase; Folic Acid; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Genetic; Risk | 2006 |
Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Topics: Adenoma; Aged; Biomarkers, Tumor; Carbon; Colorectal Neoplasms; Dietary Supplements; DNA Methylation; Female; Folic Acid; Genotype; Homeostasis; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Genetic; Prospective Studies; Risk Factors; Vitamins | 2006 |
Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer.
Topics: Cancer Vaccines; Carcinoma, Papillary; Carrier Proteins; Cystadenocarcinoma, Serous; Dendritic Cells; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Receptors, Cell Surface; RNA, Messenger; Transfection; Vaccination | 2007 |
Chemoprevention for colorectal cancer: some progress but a long way to go.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Folic Acid; Hematinics; Humans; Neoplasm Recurrence, Local; Risk Factors | 2008 |
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine; Vitamin B 12 | 2008 |
Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.
Topics: Adenoma; Aged; Alleles; Colorectal Neoplasms; Female; Folic Acid; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Surveys and Questionnaires; Vitamin B Complex | 2008 |
Aspirin helps prevent recurring colorectal adenomas--folic acid does not.
Topics: Adenoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotherapy, Adjuvant; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Female; Folic Acid; Hematinics; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic | 2008 |
Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence.
Topics: Adenoma; Adult; Aged; Animals; Aspirin; Calcium Compounds; Colorectal Neoplasms; Dairy Products; Female; Folic Acid; Humans; Male; Middle Aged; Milk; Neoplasm Recurrence, Local; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Calcitriol; Risk Assessment; Risk Factors; Surveys and Questionnaires; Transcription Factors; United Kingdom; Vitamin D | 2008 |
[After care following partial and total gastrectomy].
Topics: Aftercare; Dumping Syndrome; Esophagitis, Peptic; Folic Acid; Gastrectomy; Gastritis; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Iron; Neoplasm Recurrence, Local; Nutritional Requirements; Vitamin B 12 | 1984 |
Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma.
Topics: Adult; Antineoplastic Agents; Carcinoma; Chemotaxis, Leukocyte; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Connective Tissue; Eosinophilia; Eosinophils; Female; Fluorouracil; Folic Acid; Humans; Immunologic Factors; Immunotherapy; Interleukin-2; Leukocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Premedication; Prognosis; Recombinant Proteins; Treatment Outcome | 1995 |